|Articles|November 5, 2019
Effect of Omidria on pain and opioid usage during cataract surgery
Author(s)Michelle Dalton, ELS
Advertisement
See more content from the 2019 American Academy of Ophthalmology's annual meeting
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Related Articles
- The European Commission grants marketing authorization for EYLUXVI
September 23rd 2025
- Luxa Biotechnology announces clinical trial results for treatment of AMD
September 22nd 2025
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Idebenone accepted by FDA for priority review for Leber Hereditary Optic Neuropathy
2
Luxa Biotechnology announces clinical trial results for treatment of AMD
3
STAAR Surgical confirms expiration of “window shop” period in Alcon merger agreement
4
The European Commission grants marketing authorization for EYLUXVI
5